(Q39457556)
Statements
Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model (English)
M Verreault
D Strutt
D Masin
M Anantha
scientific article published on 5 October 2011
No description defined